Petru Iulian Ifteni, Victoria Burtea, Andreea Silvana Szalontay, Marius Alexandru Moga



One of the major problems in ethics of schizophrenia includes treatment in prodromal phase of the disease because of the potential devastating impact on human life and critical impact on their families.


Ethnic groups, social and economic status, high levels of negative symptoms, personality disorders may be factors affecting prognosis and disease progression.


Accurate and comprehensive assessment of onset of symptoms made by an experienced psychiatrist and early initiation of treatment, constitute decisive factors in the evolution and prognosis of patients with schizophrenia. The biggest challenge is such as early recognition of symptoms of disease while minimizing the risk of false diagnosis.


The average duration of prodromal symptoms before the onset of psychotic symptoms may be 2 years (women have a shorter prodromal period). Time to initiation of antipsychotic treatment is about three years, depending on the tolerance level of the community to substantial levels of psychopathology.


The stigma attributed to this disorder, which are present worldwide, can also be so powerful for family and for individuals and may determined delay of treatment.


Ethical guidelines for the research and implementation of treatment are necessary and should be followed by psychiatrists, general practitioners and families in order to ensure the right and optimal access in early stages of schizophrenia.



Full Text:



. Astǎrǎstoae V, Gavrilovici C, Vicol MC, Gergely D, Ion S. Eticǎ și non-discriminarea grupurilor vulnerabile ȋn sistemul de sǎnǎtate, 2011, Editura „Gr.T.Popa”, U.M.F. Iași.

. Bottlender R, Strauss A, Moller H. Impact of duration of symptoms prior to first hospitalization on acute outcome in 998 schizophrenic patients. Schizophr Res. 2000;44:145–150.

. Chan R C, Shum D, Toulopoulou T, Chen EY. Assessment of executive functions: review of instruments and identification of critical issues. Arch. Clin. Neuropsychol. 2008, 23, 201–216.

. Granö N, Karjalainen M, Souminen K, Roine M. Poor functioning ability is associated with high risk of developing psychosis in adolescents. Nord. J. Psychiatry. 2011;65(1):16–21.

. Gray NS, Pilowsky LS, Gray JA, Kerwin RW. Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET. Schizophr Res. 1995b;17:95–107.

. Kanahara N, Sekine Y, Haraguchi T, Uchida Y, Hashimoto K, Shimizu E, et al. 2013. Orbitofrontal cortex abnormality and deficit schizophrenia. Schizophr. Res. 143, 246–252.

. Larsen TK, Moe LC, Vibe-Hansen L, Johannessen JO. Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Schizophr Research. 2000;45: 1–9.

.Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association Between Duration of Untreated Psychosis and Outcome in Cohorts of First-Episode Patients-A Systematic Review. Arch Gen Psychiatry. 2005;62(9):975-983.

. Orellana G, Slachevsky A, Pena M. Executive attention impairment in first-episode schizophrenia. BMC Psychiatry. 2012, 12:154.

. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry .2005; 162: 1785–1804.

. Silverstein SM, Schenkel L, Valone C, Nuernberger SW. Cognitive deficits and psychiatric rehabilitation outcomes in schizophrenia. Psychiatr. Q. 1998;69, 169–191

. Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Validity of the prodromal risk syndrome for first psychosis: findings from the north American prodrome longitudinal study. Schizophr Bull. 2009;14(5):894–908.


  • There are currently no refbacks.

Comments on this article

View all comments

Copyright (c) 2015